Albuquerque-based Z-Coil Footwear is set to continue supplying pain-relieving shoes after being awarded a hefty investment on ...
Gilead Sciences' TROP2-targeting drug Trodelvy is already used as a third-line treatment for PD-L1-positive triple-negative breast cancer (TNBC), but could be heading for use in previously untreated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback